Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis.

ABSTRACT:

Rationale

The Early Pseudomonal Infection Control (EPIC) randomized trial rigorously evaluated the efficacy of different antibiotic regimens for eradication of newly identified Pseudomonas (Pa) in children with cystic fibrosis (CF). Protocol based therapy in the trial was provided based on culture positivity independent of symptoms. It is unclear whether outcomes observed in the clinical trial were different than those that would have been observed with historical standard of care driven more heavily by respiratory symptoms than culture positivity alone. We hypothesized that the incidence of Pa recurrence and hospitalizations would be significantly reduced among trial participants as compared to historical controls whose standard of care preceded the widespread adoption of tobramyc

SUBMITTER: Mayer-Hamblett N 

PROVIDER: S-EPMC4059359 | biostudies-literature | 2013 Oct

REPOSITORIES: biostudies-literature